Company intelligence / Profile preview

Hangzhou Simo

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~3600
Development stage: Other

Overview

Hangzhou Simo is a leading provider of on-site site management services (SMO) for clinical trials in China. It supports logistics and operational management for clinical research at trial sites, enabling efficient and standardized execution of clinical studies. Simo serves a broad hospital network, contributes to domestic and international studies, and is fully owned by Tigermed, a prominent clinical research organization.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Hangzhou Simo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Simo.

Explore the full profile